Learn / PCVX
NASDAQ: PCVX
Vaxcyte (PCVX) stock, explained like you're 5
Vaxcyte trades on the Nasdaq under the ticker PCVX. It is a large cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 10.6 billion dollars.
- Ticker
- PCVX
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Biological Products (No Diagnostic Substances)
- Size
- Large cap, about 10.6 billion dollars
Is Vaxcyte a small, medium or large cap company?
Yes. Vaxcyte is a large cap stock. Its market cap, which is the total value of all its shares, is about 10.6 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Vaxcyte makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves PCVX stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Vaxcyte Shares Rise 50% After VAX 31 Meets Primary Endpoints in Phase 3 Trial (Yahoo Finance)
- Vaxcyte’s stock jumps as pneumococcal vaccine holds its own against Pfizer's, Merck’s shots (Fierce Biotech)
- Vaxcyte Stock Spikes 27% as Lead Vaccine Candidate Takes Aim at Pfizer and Merck (Barron's)
- Small Biotech Squares Up To Pfizer, Merck In $7 Billion Market (Investor's Business Daily)
- Guggenheim raises Vaxcyte stock price target on vaccine trial win (Investing.com)
Follow PCVX in your daily brief
Each trading day at 5 PM ET we post what happened to Vaxcyte and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow PCVX
Questions about Vaxcyte stock
What does Vaxcyte do?
Vaxcyte trades on the Nasdaq under the ticker PCVX. It is a large cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 10.6 billion dollars.
What is the ticker symbol for Vaxcyte?
Vaxcyte trades under the ticker PCVX on the Nasdaq.
What is Vaxcyte's market cap?
Vaxcyte is a large cap stock with a market cap of about 10.6 billion dollars.
How does Vaxcyte make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves PCVX stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow PCVX stock every day?
Add PCVX to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.